Ternary complex between VCB, BRD4-BD2 and PROTAC 51

Ternary complex between VCB, BRD4-BD2 and PROTAC 51 Descriptor: (2~{S},4~{R})-~{N}-[(1~{S})-3-[2-[2-[2-[2-[2-[(9~{S})-7-(4-chlorophenyl)-4,5,13-trimethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.0^{2,6}]trideca-2(6),4,7,10,12-pentaen-9-yl]ethanoylamino]ethoxy]ethoxy]ethoxy]ethylamino]-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]-3-oxidanylidene-propyl]-1-[(2~{R})-3-methyl-2-(3-methyl-1,2-oxazol-5-yl)butanoyl]-4-oxidanyl-pyrrolidine-2-carboxamide, Bromodomain-containing protein 4, Elongin-B, ... Authors: Sorrell, F.J, Mueller, J.E, Lehmann, M, Wegener, A.A. Deposit date: 2022-10-20 Release date: 2023-02-15 Last modified: 2024-02-07 Method: X-RAY DIFFRACTION (2.7 Å) Cite: Systematic Potency and Property Assessment of VHL Ligands and Implications on PROTAC Design. Chemmedchem, 18, 2023VCB、BRD4-BD2与蛋白水解靶向嵌合体（PROTAC）51形成的三元复合物，其描述符为：(2S,4R)-N-[(1S)-3-[2-[2-[2-[2-[2-[(9S)-7-(4-氯苯基)-4,5,13-三甲基-3-硫杂-1,8,11,12-四氮杂三环[8.3.0.0²,⁶]十三烷-2(6),4,7,10,12-五烯-9-基]乙酰胺基]乙氧基]乙氧基]乙氧基]乙基氨基]-1-[4-(4-甲基-1,3-噻唑-5-基)苯基]-3-氧代丙基]-1-[(2R)-3-甲基-2-(3-甲基-1,2-恶唑-5-基)丁酰基]-4-羟基吡咯烷-2-甲酰胺、含溴结构域蛋白4（Bromodomain-containing protein 4）、延伸蛋白B（Elongin-B）等。作者：Sorrell F.J.、Mueller J.E.、Lehmann M.、Wegener A.A.。入库日期：2022-10-20；发布日期：2023-02-15；最后修改日期：2024-02-07。实验方法：X射线衍射（2.7 Å）。引用文献：《VHL配体的系统药效与性质评估及其对PROTAC设计的启示》，发表于Chemmedchem，2023年，第18卷。